| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study
|
de Marinis, Filippo
|
|
|
152 |
C |
p. 127-134
|
artikel
|
| 2 |
A possible EGFR TKIs resistance mechanism of lung adenocarcinoma patients with a novel EGFR exon 20-ins mutation: A case report
|
Liang, Ping
|
|
|
152 |
C |
p. 193-195
|
artikel
|
| 3 |
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
|
Griesinger, Frank
|
|
|
152 |
C |
p. 174-184
|
artikel
|
| 4 |
Cancer treatment in the coronavirus disease pandemic
|
Zhang, Jia-Tao
|
|
|
152 |
C |
p. 98-103
|
artikel
|
| 5 |
Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors
|
Takamori, Shinkichi
|
|
|
152 |
C |
p. 27-33
|
artikel
|
| 6 |
Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study
|
Blake-Cerda, Mónika
|
|
|
152 |
C |
p. 119-126
|
artikel
|
| 7 |
Contents
|
|
|
|
152 |
C |
p. v-vii
|
artikel
|
| 8 |
CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma
|
Berger, I.
|
|
|
152 |
C |
p. 34-38
|
artikel
|
| 9 |
Dacomitinib induces objective responses in metastatic brain lesions of patients with EGFR-mutant non-small-cell lung cancer: A brief report
|
Peng, Wenying
|
|
|
152 |
C |
p. 66-70
|
artikel
|
| 10 |
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors
|
Abbar, B.
|
|
|
152 |
C |
p. 109-118
|
artikel
|
| 11 |
Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients
|
Cai, Chengzhi
|
|
|
152 |
C |
p. 104-108
|
artikel
|
| 12 |
Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?
|
Thomas, Pascal-Alexandre
|
|
|
152 |
C |
p. 86-93
|
artikel
|
| 13 |
Editorial Board
|
|
|
|
152 |
C |
p. iii
|
artikel
|
| 14 |
Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database
|
Shibata, Yuji
|
|
|
152 |
C |
p. 199-201
|
artikel
|
| 15 |
Extensive functional evaluation of exon 20 insertion mutations of EGFR
|
Hirose, Takeshi
|
|
|
152 |
C |
p. 135-142
|
artikel
|
| 16 |
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer
|
Ronden, Merle I.
|
|
|
152 |
C |
p. 149-156
|
artikel
|
| 17 |
Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid
|
Kwok, Wang Chun
|
|
|
152 |
C |
p. 15-20
|
artikel
|
| 18 |
Identification of a novel NPM1-ROS1 fusion in a lung adenocarcinoma and sensitive to crizotinib treatment
|
Ma, Hongxia
|
|
|
152 |
C |
p. 196-198
|
artikel
|
| 19 |
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
|
Lobefaro, Riccardo
|
|
|
152 |
C |
p. 165-173
|
artikel
|
| 20 |
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)
|
Lu, Shun
|
|
|
152 |
C |
p. 7-14
|
artikel
|
| 21 |
NSCLC patients with MET non-exon-14 mutations rather than MET exon 14 mutations response to immune checkpoint inhibitors
|
Li, Xuanzong
|
|
|
152 |
C |
p. 202-204
|
artikel
|
| 22 |
Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations
|
Yang, Guang-Jian
|
|
|
152 |
C |
p. 39-48
|
artikel
|
| 23 |
Outcomes of nodal upstaging comparing video-assisted thoracoscopic surgery versus open thoracotomy for lung cancer
|
Matsuura, Yosuke
|
|
|
152 |
C |
p. 78-85
|
artikel
|
| 24 |
Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection
|
Chae, Mincheol
|
|
|
152 |
C |
p. 21-26
|
artikel
|
| 25 |
Rare coexistence of three novel CDCA7-ALK, FSIP2-ALK, ALK-ERLEC1 fusions in a lung adenocarcinoma patient who responded to Crizotinib
|
Zhao, Guojiang
|
|
|
152 |
C |
p. 189-192
|
artikel
|
| 26 |
Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma
|
Ghirardelli, Paolo
|
|
|
152 |
C |
p. 1-6
|
artikel
|
| 27 |
Stomatitis associated with osimertinib in advanced lung cancer treatment: Characterization and implications for management
|
Vigarios, Emmanuelle
|
|
|
152 |
C |
p. 185-188
|
artikel
|
| 28 |
Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?
|
Gendarme, Sébastien
|
|
|
152 |
C |
p. 94-97
|
artikel
|
| 29 |
Subclinical myasthenia gravis in thymomas
|
Marcuse, Florit
|
|
|
152 |
C |
p. 143-148
|
artikel
|
| 30 |
Surgery for small cell lung cancer: When and how
|
Casiraghi, Monica
|
|
|
152 |
C |
p. 71-77
|
artikel
|
| 31 |
Temporal trends of the lung cancer mortality attributable to smoking from 1990 to 2017: A global, regional and national analysis
|
Yang, Xiaorong
|
|
|
152 |
C |
p. 49-57
|
artikel
|
| 32 |
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients
|
Jiang, Mei
|
|
|
152 |
C |
p. 58-65
|
artikel
|
| 33 |
Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives
|
Lazarev, Stanislav
|
|
|
152 |
C |
p. 157-164
|
artikel
|
Tijdschrift beschrijving